Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
about
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityPolymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenSurvival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriersSociety of Gynecologic Oncology recommendations for the prevention of ovarian cancerChallenging and complex decisions in the management of the BRCA mutation carrierCigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group studyHormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyGlucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Hormonal contraception and risk of cancer.Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.Tubal ligation and the risk of ovarian cancer: review and meta-analysis.Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutationsCancer genetics: risks and mechanisms of cancer in women with inherited susceptibility to epithelial ovarian cancerGenetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskObesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early DetectionTubal ligation, hysterectomy and ovarian cancer: A meta-analysis.Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: identification of a BRCA1 ovarian cancer phenotype.Endometrial and ovarian cancer in lynch syndrome.Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutationsGenetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.Opportunistic salpingectomy for ovarian cancer preventionManagement options after prophylactic surgeries in women with BRCA mutations: a review.Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studiesThe Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses.Genetic risk and gynecologic cancers.Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registryCombined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality.BRCA mutations in the manifestation and treatment of ovarian cancer.Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort.The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.
P2860
Q24200437-4CADF6C1-F5D5-4003-9C32-A27365DD49A9Q24648412-C0C72F8D-B457-4C8E-8EA9-DE9ECE842F50Q24654487-AB795464-0E3E-4C25-8E2E-C2834EC35E85Q27009306-2D2A1A14-27FC-4F47-A625-EB772512A132Q27026559-42EC4E71-75ED-47DD-9DE7-A3689B3A1177Q30275068-4CBE2478-6E8A-4A84-8651-979CF48CC3EFQ30277151-A4ED22D7-40A5-4152-BEC5-FD0153A67EF2Q30431721-EC89982A-A894-4723-9234-47C207638211Q33551425-2275F2FE-69CF-4F57-9F79-656D89441215Q33645478-EE431E9B-6F24-4892-A7D6-7B0AC64FFF22Q34120493-8C68CD4D-75F8-4C3C-843B-CD9DCD2541B0Q34126089-03686BAB-22A2-44E8-9D8B-0D30B8C67750Q34126227-3AB87483-63DD-4517-B707-E5B144D34258Q34216239-C75C919C-F7DD-4695-A03A-6BA759A42778Q34274328-7F0E8EE7-22CB-43C2-BFC6-0923A507A294Q34338047-E6F7873F-8722-431F-AA33-F7E9543A34EDQ34811314-8AF4ED77-B239-4A2C-94E6-CF153FB9CB55Q34910918-262CB2D9-F139-48FD-AB5A-C980FFDA1146Q34955369-BF0643A6-B09A-4074-8927-6E2214CE233CQ36027025-AA46320B-DD46-4018-A879-7D6972159428Q36039369-A8AB9A03-3855-4568-BA7A-194F2379571AQ36068441-5560DAD8-CB13-4FD5-AC35-CD44A4728659Q36173170-CA4929C4-513C-4867-94BA-F94DBAE0B350Q36178261-97D7AB66-478A-43A2-9915-E56963869613Q36696565-62C34AB8-1A42-475C-ACA8-8D00F87E25B3Q36843211-395019AD-62CE-4E3B-87C6-A525F03D6566Q36938143-7113ACC1-0CE4-439C-B7F2-B6C0456750EDQ36959824-3492FCEC-2C20-4330-97E0-898B3C942BBAQ37151786-85382977-54EC-4CB2-9599-11DA152D964EQ37169663-1811F5FF-4B28-4D83-BC3A-089908799560Q37282647-983955CC-306C-4983-B248-EFD6D21E6E8DQ37455898-C47EC25A-C695-406E-B234-FD2DF4414BCBQ37468316-8AAF2ECD-703D-4D14-9815-F3920F3B9A1DQ37594378-479DD2DE-9906-4F1B-AC9D-AC0167AAEC79Q37657957-DDEB9AA3-D102-4DAD-97AF-109DA561705CQ39326953-67F71352-FCB5-4534-8969-569A7EB7132CQ46343159-6BE79D63-A1E8-4614-B243-BD96C996C3A6Q47134293-23BA4C0E-00FF-4DA0-8BCB-35E0475BC527Q50629535-9546C1E1-9D81-4FE2-9B17-AB71ED05ECEAQ50709318-F7809C0F-5B06-40E0-89E6-5356EB84A249
P2860
Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Relation of contraceptive and ...... riers of BRCA1 gene mutations.
@en
Relation of contraceptive and ...... riers of BRCA1 gene mutations.
@nl
type
label
Relation of contraceptive and ...... riers of BRCA1 gene mutations.
@en
Relation of contraceptive and ...... riers of BRCA1 gene mutations.
@nl
prefLabel
Relation of contraceptive and ...... riers of BRCA1 gene mutations.
@en
Relation of contraceptive and ...... riers of BRCA1 gene mutations.
@nl
P2093
P356
P1476
Relation of contraceptive and ...... riers of BRCA1 gene mutations.
@en
P2093
DiCioccio R
Whittemore AS
P304
P356
10.1093/AJE/KWH284
P407
P577
2004-10-01T00:00:00Z